BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27601681)

  • 1. Pathological Ace2-to-Ace enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1-FoxM1 complex.
    Yang J; Feng X; Zhou Q; Cheng W; Shang C; Han P; Lin CH; Chen HS; Quertermous T; Chang CP
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5628-35. PubMed ID: 27601681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
    Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
    Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long noncoding RNA protects the heart from pathological hypertrophy.
    Han P; Li W; Lin CH; Yang J; Shang C; Nuernberg ST; Jin KK; Xu W; Lin CY; Lin CJ; Xiong Y; Chien H; Zhou B; Ashley E; Bernstein D; Chen PS; Chen HV; Quertermous T; Chang CP
    Nature; 2014 Oct; 514(7520):102-106. PubMed ID: 25119045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin regulation by Brg1 underlies heart muscle development and disease.
    Hang CT; Yang J; Han P; Cheng HL; Shang C; Ashley E; Zhou B; Chang CP
    Nature; 2010 Jul; 466(7302):62-7. PubMed ID: 20596014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic response to environmental stress: Assembly of BRG1-G9a/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed hearts.
    Han P; Li W; Yang J; Shang C; Lin CH; Cheng W; Hang CT; Cheng HL; Chen CH; Wong J; Xiong Y; Zhao M; Drakos SG; Ghetti A; Li DY; Bernstein D; Chen HS; Quertermous T; Chang CP
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1772-81. PubMed ID: 26952936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy.
    Weng X; Yu L; Liang P; Li L; Dai X; Zhou B; Wu X; Xu H; Fang M; Chen Q; Xu Y
    J Mol Cell Cardiol; 2015 May; 82():48-58. PubMed ID: 25712920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.
    Mehta G; Kumarasamy S; Wu J; Walsh A; Liu L; Williams K; Joe B; de la Serna IL
    J Mol Cell Cardiol; 2015 Nov; 88():101-10. PubMed ID: 26388265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling.
    Sato T; Kadowaki A; Suzuki T; Ito H; Watanabe H; Imai Y; Kuba K
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual roles of chromatin remodeling protein BRG1 in angiotensin II-induced endothelial-mesenchymal transition.
    Li Z; Kong X; Zhang Y; Zhang Y; Yu L; Guo J; Xu Y
    Cell Death Dis; 2020 Jul; 11(7):549. PubMed ID: 32683412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure.
    Wang J; Li N; Gao F; Song R; Zhu S; Geng Z
    J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):553-8. PubMed ID: 25869724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
    Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
    J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of the chromatin remodeling factor DPF3a induces cardiac hypertrophy through releasing HEY repressors from DNA.
    Cui H; Schlesinger J; Schoenhals S; Tönjes M; Dunkel I; Meierhofer D; Cano E; Schulz K; Berger MF; Haack T; Abdelilah-Seyfried S; Bulyk ML; Sauer S; Sperling SR
    Nucleic Acids Res; 2016 Apr; 44(6):2538-53. PubMed ID: 26582913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice.
    Nakamura K; Koibuchi N; Nishimatsu H; Higashikuni Y; Hirata Y; Kugiyama K; Nagai R; Sata M
    Hypertens Res; 2008 Oct; 31(10):1953-61. PubMed ID: 19015603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brahma-related gene 1 (Brg1) epigenetically regulates CAM activation during hypoxic pulmonary hypertension.
    Chen D; Fang F; Yang Y; Chen J; Xu G; Xu Y; Gao Y
    Cardiovasc Res; 2013 Dec; 100(3):363-73. PubMed ID: 24042015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
    Keidar S; Kaplan M; Gamliel-Lazarovich A
    Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE2 deficiency induced perivascular fibrosis and cardiac hypertrophy during postnatal development in mice.
    Moritani T; Iwai M; Kanno H; Nakaoka H; Iwanami J; Higaki T; Ishii E; Horiuchi M
    J Am Soc Hypertens; 2013; 7(4):259-66. PubMed ID: 23608725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
    Yamamoto K; Ohishi M; Katsuya T; Ito N; Ikushima M; Kaibe M; Tatara Y; Shiota A; Sugano S; Takeda S; Rakugi H; Ogihara T
    Hypertension; 2006 Apr; 47(4):718-26. PubMed ID: 16505206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiotensin II on rhythmic per2 expression in the suprachiasmatic nucleus and heart and daily rhythm of activity in Wistar rats.
    Herichová I; Šoltésová D; Szántóová K; Mravec B; Neupauerová D; Veselá A; Zeman M
    Regul Pept; 2013 Sep; 186():49-56. PubMed ID: 23850797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.